Skip to main content

. 1965 Mar 6;1(5435):628–631. doi: 10.1136/bmj.1.5435.628

Natulan in Management of Late Hodgkin's Disease, Other Lymphoreticular Neoplasms, and Malignant Melanoma

PMCID: PMC2166027 PMID: 14245179

628

Images in this article

Fig. 1
on p.629

Fig. 2
on p.629

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Easson E. C., Russell M. H. Cure of Hodgkin's Disease. Br Med J. 1963 Jun 29;1(5347):1704–1707. doi: 10.1136/bmj.1.5347.1704. [DOI] [PMC free article] [PubMed] [Google Scholar]
MATHE G., SCHWEISGUTH O., SCHNEIDER M., AMIEL J. L., BERUMEN L., BRULE G., CATTAN A., SCHWARZENBERG L. METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HAEMATOSARCOMA AND LEUKAEMIA. Lancet. 1963 Nov 23;2(7317):1077–1080. doi: 10.1016/s0140-6736(63)92854-x. [DOI] [PubMed] [Google Scholar]
SICHER K., BACKHOUSE T. W. METHYL-HYDRAZINE IN MALIGNANT DISEASE. Lancet. 1963 Dec 14;2(7320):1278–1279. doi: 10.1016/s0140-6736(63)90926-7. [DOI] [PubMed] [Google Scholar]
ZELLER P., GUTMANN H., HEGEDUS B., KAISER A., LANGEMANN A., MULLER M. Methylhydrazine derivatives, a new class of cytotoxic agents. Experientia. 1963 Mar 15;19:129–129. doi: 10.1007/BF02171588. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES